EPHA4 and neoplasm: Myeloid cell precursors of EMH were very rare or markedly reduced in the liver of EphA4‐KO tumor‐bearing mice without IGF1 treatment, but markedly increased with IGF1 administration (Fig. 5E, F‐1, F‐2).